<img alt="" height="1" width="1" />Pharmos Corporation Reports First Quarter 2010 ResultsPR-USA.net (press release)The Company's lead product, Dextofisopam for diarrhea predominant irritable bowel syndrome (IBS-D) has been advanced through Phase 2b. ...<nobr>and more »</nobr> |